Swiss National Bank’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-147,400
| Closed | -$3.52M | – | 2677 |
|
|
2021
Q1 | $3.52M | Buy |
147,400
+2,800
| +2% | +$52K | ﹤0.01% | 1672 |
|
|
2020
Q4 | $2.11M | Buy |
144,600
+1,300
| +0.9% | +$17.2K | ﹤0.01% | 1874 |
|
|
2020
Q3 | $2.04M | Buy |
143,300
+4,400
| +3% | +$67.2K | ﹤0.01% | 1714 |
|
|
2020
Q2 | $2.04M | Buy |
138,900
+37,500
| +37% | +$381K | ﹤0.01% | 1701 |
|
|
2020
Q1 | $418K | Buy |
101,400
+4,600
| +5% | +$21.6K | ﹤0.01% | 2252 |
|
|
2019
Q4 | $466K | Hold |
96,800
| – | – | ﹤0.01% | 2435 |
|
|
2019
Q3 | $587K | Hold |
96,800
| – | – | ﹤0.01% | 2301 |
|
|
2019
Q2 | $628K | Hold |
96,800
| – | – | ﹤0.01% | 2344 |
|
|
2019
Q1 | $686K | Buy |
96,800
+3,100
| +3% | +$20.4K | ﹤0.01% | 2267 |
|
|
2018
Q4 | $455K | Buy |
93,700
+4,700
| +5% | +$24.5K | ﹤0.01% | 2384 |
|
|
2018
Q3 | $654K | Hold |
89,000
| – | – | ﹤0.01% | 2344 |
|
|
2018
Q2 | $568K | Hold |
89,000
| – | – | ﹤0.01% | 2412 |
|
|
2018
Q1 | $484K | Hold |
89,000
| – | – | ﹤0.01% | 2382 |
|
|
2017
Q4 | $371K | Hold |
89,000
| – | – | ﹤0.01% | 2468 |
|
|
2017
Q3 | $857K | Hold |
89,000
| – | – | ﹤0.01% | 2153 |
|
|
2017
Q2 | $1.05M | Buy |
89,000
+24,200
| +37% | +$309K | ﹤0.01% | 2025 |
|
|
2017
Q1 | $831K | Hold |
64,800
| – | – | ﹤0.01% | 2139 |
|
|
2016
Q4 | $793K | Hold |
64,800
| – | – | ﹤0.01% | 2179 |
|
|
2016
Q3 | $765K | Hold |
64,800
| – | – | ﹤0.01% | 2143 |
|
|
2016
Q2 | $564K | Hold |
64,800
| – | – | ﹤0.01% | 2289 |
|
|
2016
Q1 | $330K | Buy |
64,800
+12,200
| +23% | +$67.9K | ﹤0.01% | 2466 |
|
|
2015
Q4 | $408K | Hold |
52,600
| – | – | ﹤0.01% | 2374 |
|
|
2015
Q3 | $414K | Buy |
52,600
+8,400
| +19% | +$77.7K | ﹤0.01% | 2279 |
|
|
2015
Q2 | $400K | Hold |
44,200
| – | – | ﹤0.01% | 2341 |
|
|
2015
Q1 | $574K | Hold |
44,200
| – | – | ﹤0.01% | 2101 |
|
|
2014
Q4 | $602K | Hold |
44,200
| – | – | ﹤0.01% | 2063 |
|
|
2014
Q3 | $396K | Hold |
44,200
| – | – | ﹤0.01% | 2222 |
|
|
2014
Q2 | $598K | Buy |
+44,200
| New | +$461K | ﹤0.01% | 2063 |
|
Swiss National Bank's GNMK Position: Q2 2021 in Review
Swiss National Bank sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 147,400 shares — an estimated $3.52M sold.
Swiss National Bank first reported a position in GNMK in Q2 2014 and held it in 28 quarters. The position peaked at $3.52M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Swiss National Bank reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Swiss National Bank sold 147,400 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $3.52M.
- Swiss National Bank first reported a position in GenMark Diagnostics, Inc in Q2 2014 and held it in 28 quarters.
- Swiss National Bank's GenMark Diagnostics, Inc position peaked at $3.52M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.